Meltz Mark A

Meltz Mark A is listed in filings as General Counsel at Lyell Immunopharma, Inc.. This profile follows SEC Form 4 activity through Feb 11, 2026, including 2 public disclosures. Recent filings connect the profile to Lyell Immunopharma, Inc. (LYEL). The current snapshot covers public activity from Jun 11, 2025 to Feb 11, 2026. Reported amounts are shown as $1.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.